Latest
Times in ET
  1. REGN +0.72%· via Yahoo

    Regeneron Pharmaceuticals shares trade at $803.90, up 33% over one year

    Regeneron Pharmaceuticals Inc (REGN) closed at $803.90, gaining 0.72% in the session. The biotechnology company's stock has returned 33.31% over the past year, positioning it at 82.6% of its 52-week range. The company reported Q2 FY2026 EPS of 14.29, beating the 10.47 estimate by 36.51%.

  2. WFC -3.92%· via Yahoo

    Wells Fargo Commits $5M to Affordable Housing and Workforce Training in Five-State Initiative

    Wells Fargo & Co (WFC) common stock fell 3.92% to $83.15. The bank and its foundation announced a $5 million philanthropic commitment across five states to expand affordable housing and develop skilled labor capacity. The stock trades at 41.5% of its 52-week range of $72.78 to $97.76.

  3. WELL -1.02%· via Yahoo

    Welltower Inc (WELL) Trades at $230.39 After 217% Five-Year Gain

    Welltower Inc (WELL) closed at $230.39, down 1.02% in the session, following a 216.9% rise over the past five years. The real estate investment trust now carries a market capitalization of $169.8B. The stock trades 72.9% of the way through its 52-week range of $163.75 to $255.20.

  4. MSTR -0.69%· via Yahoo

    Strategy Inc shares trade at $167.33 as analyst sees potential gain

    Strategy Inc (MSTR) closed at $167.33, down 0.69% on the session. An analyst forecast the stock could rise by 35%, citing the company's unrealized gain of approximately $9 billion on its Bitcoin holdings. The stock has gained 24.21% over six months but remains down 51.74% over the past year.

8 more today

Advertisement

Live Market Pulse
More AnalysisView All →
Why Money365.Market?

Real-Time Data

Live market data, charts, and analytics powered by industry-leading providers.

Advanced Screening

Filter stocks by P/E, market cap, dividend yield, and dozens of other metrics.

Expert Analysis

Professional market analysis, investment strategies, and actionable insights.

Newsletter

Weekly Market Insights

Get expert market analysis and investment ideas delivered to your inbox every week.